Department of Clinical Social Medicine, Occupational and Environmental Dermatology, University Hospital Heidelberg, DE-69115 Heidelberg, Germany.
Acta Derm Venereol. 2019 Apr 1;99(4):423-428. doi: 10.2340/00015555-3125.
The GEHIS (German Epidemiological Hemodialysis Itch Study) is a representative cohort study started in 2013 with 860 haemodialysis (HD) patients in 25 German dialysis units. Chronic itch (CI) has been reported to be a poor prognostic marker for patients on HD; however, this has not been investigated in a representative patient cohort. In 2017, all HD patients were contacted again to investigate mortality in those with and without CI and to identify its determinants. Patients' characteristics, study instruments and CI were assessed, as in 2013. The response rate was 84.2% (n = 724). One-year mortality was 15.3%. Mortality was significantly higher in those with secondary scratch lesions compared with those with non-affected skin. This was also true after controlling for age and sex in a multivariate model. This study demonstrates a high mortality in HD patients; however, mortality depends on itch intensity, not on the occurrence of CI itself.
德国流行病学血液透析瘙痒研究(GEHIS)是一项代表性队列研究,于 2013 年启动,纳入了 25 家德国透析中心的 860 名血液透析(HD)患者。慢性瘙痒(CI)已被报道为 HD 患者的预后不良标志物;然而,这尚未在代表性患者队列中进行研究。2017 年,再次联系所有 HD 患者,以调查有和无 CI 患者的死亡率,并确定其决定因素。评估了患者的特征、研究工具和 CI,与 2013 年相同。应答率为 84.2%(n=724)。一年死亡率为 15.3%。与无皮损的患者相比,有继发性搔抓皮损的患者死亡率显著更高。在多变量模型中控制年龄和性别后也是如此。这项研究表明 HD 患者的死亡率较高;然而,死亡率取决于瘙痒强度,而不是 CI 的发生本身。